XMax Inc. (XMAX) fair value analysis
Nasdaq · Updated 2026-10-19
XMAX price how computed
Valuation status
No fair-value estimate yetXMAX has no usable analyst consensus for next fiscal year's earnings, or too few reported quarters for our trailing P/E history.
Forward Fair Value needs both, so TickrTrends publishes no verdict for XMAX yet. We re-check every week; the price, fundamentals, technicals and earnings data below are unaffected.
- Last price
- $8.10
- Sector
- Consumer Cyclical
- 12-month range
- $5.20–$9.34
- Market cap
- $525M
- From 52-week high
- -13.3%
- Shares outstanding
- 64.9M
- Rank in Consumer Cyclical by quality score
- #76 of 113
Last price is the 2026-10-16 close; the chart runs through 2026-10-16.
XMax Inc. is a consumer cyclical company that designs and manufactures vaping and cannabis consumption devices. The company operates primarily in the United States market.
XMAX currently ranks #76 of 113 Consumer Cyclical stocks by quality score.
Fundamentals (4 quarters) how computed
- Market cap
- $525M
- P/E (trailing)
- n/m
- Revenue (TTM)
- $16M
- Net margin
- 185.9%
- EPS (TTM)
- $-0.12
- Gross margin
- 39.8%
- Debt / equity
- 0.05
- Shares outstanding
- 64.9M
Derived indicators how computed
- Quality grade
- F
- 52-week position
- The upper-middle quarter of its range
Technicals how computed
- RSI (14-day)
- 30 · oversold
- 50-day average
- $8.77
- 200-day average
- $7.74
- Moving-average state
- 50-day above 200-day (golden cross state); price between the averages
Earnings how computed
- Next earnings report
- 2026-11-13
What our data shows for XMAX
- Shares are trading in the upper third of their 12-month price range of $5.20–$9.34.
- The 14-day relative strength index sits at an oversold 30.
What subscribers see
- Every published Forward Fair Value with its exact discount or premium
- The normalized P/E and quarter count behind each estimate
- Screeners and rankings across the full S&P 500 and Nasdaq universes
- XMAX's own verdict the week it qualifies, published automatically
Forward Fair Value applies a conservatively normalized historical price-to-earnings multiple to the consensus earnings estimate for the next full fiscal year; how TickrTrends computes it.
What people are saying
Follow the XMAX conversation: Stocktwits · Reddit · X
TickrTrends weekly updates
- 2026-10-19 — XMAX, a Consumer Cyclical sector stock, moved into oversold territory this week as its RSI zone shifted from neutral. The stock's derived indicators are currently awaiting full valuation assessment.
- 2026-10-12 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-11 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-10 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-06 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-05 — No material change this week: the verdict, bands and grades all held steady.
- 2026-09-28 — TickrTrends initiated weekly Forward Fair Value coverage of this stock.
Frequently asked questions
Is XMAX stock undervalued?
TickrTrends has no fair-value estimate for XMAX yet: there is no usable analyst consensus for next fiscal year's earnings, or too few reported quarters for a trailing P/E history. It is re-checked every week.
What is XMAX's TickrTrends verdict?
XMAX is currently marked 'No fair-value estimate yet' - a verdict publishes automatically once a forward earnings consensus and enough reported quarters are available.
How does XMAX compare to other Consumer Cyclical stocks?
XMAX ranks #76 of 113 Consumer Cyclical stocks in TickrTrends' coverage by quality score. It carries no fair-value verdict yet, so it is not ranked by discount.
Is XMAX overbought or oversold?
XMAX's 14-day RSI is in the oversold zone on TickrTrends' latest weekly data.
When does XMAX report earnings next?
XMAX's next earnings report is scheduled for 2026-11-13, per the published earnings calendar.